No Data
December 27 [Today's Investment Strategy]
[Selected Stocks by Fisco] 【Material Stocks】 Kaken Pharmaceutical <4521> 4174 yen (12/26) Main products include the nail fungus treatment 'Klenafin' and the joint function improvement drug 'Alts'. The company announced the signing of a contract granting Johnson & Johnson exclusive rights for the development, manufacturing, and commercialization globally of the 'STAT6 Program', which is being developed as a next-generation oral treatment for type 2 inflammatory diseases (such as atopic dermatitis and asthma).
List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
○ List of stocks transitioning to Buy market Code Stock Name Closing Price SAR Main Board <1518> Mitsui Matsushima HD 3575 3155 <1803> Shimizu Construction 12381177 <1815> Tekken 22852195 <1945> Tokyo Energy System 10571032 <2060> Feed One 778752 <2220> Kameda Confectionery 41503990 <2337> Ichigo 367351 <2379> Dip 244
Jaccs: Confirmation letter
Jaccs: Half-Year Report - Term 94 (2024/04/01 - 2025/03/31)
List of stocks with cleared clouds (Part 2) [Ichimoku Kinko Hyo: List of Stocks with Cleared Clouds]
List of breakout stocks under the clouds in the market Code Stock name Closing price Leading Span A Leading Span B Tokyo Stock Exchange Main Board <1878> Daito Build 17135 17693.75 17210 <2060> Feed One 855 866.75 857 <2264> Morinaga Milk 3068 3477.25 3360.5 <2297>
Jaccs: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)